4.2 out of 5 stars
(311 Ratings)
SciSure is a Scientific Management Platform built to support the full range of laboratory operations for scientific organizations. It combines ELN, LIMS, and Health & Safety functionality, giving teams a single system to document experiments, track sample lineage, manage chemical inventory, and run structured, audit-ready compliance processes.
Instead of relying on disconnected systems, organizations get one governed platform that improves reproducibility, increases visibility into lab operations, and reduces risk as they scale.
Learn more about SciSure
4.6 out of 5 stars
(45340 Ratings)
IONOS offers GPU Servers that deliver a high-performance computing framework aimed at managing tasks that demand significantly more power than standard CPU systems can provide. This infrastructure features top-tier NVIDIA GPUs, including the H100, H200, and L40s, in addition to specialized AI accelerators like Intel Gaudi, facilitating extensive parallel processing for demanding applications. By utilizing GPU-accelerated instances, the cloud infrastructure is enhanced with dedicated graphical processors, enabling virtual machines to execute intricate calculations and handle data-heavy tasks at a much faster rate compared to traditional servers. This solution is especially well-suited for fields such as artificial intelligence, deep learning, and data science, where training models on extensive datasets or executing rapid inference processes is necessary. Furthermore, it accommodates big data analytics, scientific simulations, and visualization tasks, including 3D rendering or modeling, that necessitate substantial computational capacity. As a result, organizations seeking to optimize their processing capabilities for complex workloads can greatly benefit from this advanced infrastructure.
Learn more about IONOS Cloud GPU Servers
Bionidi
Bionidi is an innovative platform driven by artificial intelligence that caters to Medical Affairs, scientific communications, and life sciences marketing teams. It empowers these teams to transform provided publications and sanctioned brand materials into various forms of scientific content, such as presentations, medical explainer videos, infographics, and e-learning resources. The platform's workflow integrates scientific storytelling with visual design and evidence mapping, enabling reviewers to assess the connections between content and its original sources effectively. Common projects include slide decks based on publications, explanations of scientific processes, educational materials for medical professionals, and tailored adaptations for diverse audiences. The importance of human scientific review and adherence to each organization's approval procedures remains a crucial aspect of the process. Currently, Bionidi is available for commercial use, and interested parties can arrange for a demonstration based on a relevant content brief to see its capabilities in action. This allows potential users to gain insights into how Bionidi can enhance their scientific communication efforts effectively.
Learn more about Bionidi
BenchSci
Streamline the entire selection process for reagents and model systems to eliminate costly inefficiencies and errors that lead to experimental failures. Accelerate project timelines by facilitating the selection of reagents and model systems in a mere 30 seconds, compared to the traditional 12-week duration. This transformation can significantly cut the hard costs associated with consumables, saving organizations millions annually. By restoring valuable research time to scientists, you can enhance the organization’s mission. Experience tangible business benefits from AI through a proven, ready-to-use application. More than 41,200 scientists across 15 of the leading 20 pharmaceutical companies, as well as over 4,450 academic institutions, leverage BenchSci’s AI-Assisted Antibody Selection to design more effective experiments, resulting in documented savings of millions per year in hard costs alone. However, it's important to note that antibodies account for only 40-50% of reagent-related failures. Access a comprehensive array of experimental evidence, along with catalog data for reagents and model systems, all within one user-friendly interface. This platform integrates real-world experiment data sourced from 11.2 million scientific publications, including those published in closed-access journals, providing an unparalleled resource for researchers. With this level of detailed information, scientists can make informed decisions that significantly enhance their research outcomes.
Learn more about BenchSci
